A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

Clinical trial NCT07277413 · RECRUITING

Trial details

NCT number: NCT07277413
Sponsor: IDEAYA Biosciences
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

NSCLC Adenocarcinoma Gastroesophageal Cancer (GC)Gastric Adenocarcinoma Adenocarcinoma of Esophagus Squamous Cell Car. - Esophagus Urothelial Carcinoma (UC)Bladder Cancer Mesothelioma Pleural Mesothelioma Peritoneal Mesothelioma Non-Small Cell Lung Cancer NSCLC Pancreatic Cancer

Start date: 2026-03-04
Primary completion: 2028-04-30
Enrollment: 260

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.